Please login to the form below

Not currently logged in
Email:
Password:

drug development

This page shows the latest drug development news and features for those working in and with pharma, biotech and healthcare.

BenevolentAI raises $115m to fund drug development

BenevolentAI raises $115m to fund drug development

the company, which wants to use AI technology to improve and accelerate the drug development process. ... drug development company with the ability to deliver better medicines at previously unimaginable speed”.

Latest news

  • New centre aims to Catapult UK into cell and gene therapy lead New centre aims to Catapult UK into cell and gene therapy lead

    The forward-looking strategy by the government looks set to pay off - just as long as it can translate its drug development and manufacturing lead into final local market access via

  • AZ taps Ionis for another drug, this time in NASH AZ taps Ionis for another drug, this time in NASH

    AZ has played a strategic role in advancing this programme forward by providing both preclinical and development expertise in NASH that has contributed to the rapid advance of this drug into ... Last June, AZ abandoned development of NASH drug AZD4076 -

  • Parexel launches medical writing solutions business Parexel launches medical writing solutions business

    drug development and commercialisation process. ... Julia Cooper, vice president, head of global medical writing solutions at Parexel, said: “As the drug development journey continues to evolve with the advancements in trial design and technology, and

  • New industry standards group launched New industry standards group launched

    Align Clinical CRO represents an important industry collaboration to improve the trial processes and how the industry works together to accelerate drug development.”.

  • AZ finally gets EU nod for Veltassa rival Lokelma AZ finally gets EU nod for Veltassa rival Lokelma

    Drug therapy is often modified or discontinued in HF patients as a result, but this can increase the risk of death. ... Björk, who heads up AZ’s cardiovascular, renal and metabolism drug development.

More from news
Approximately 19 fully matching, plus 872 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 82 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... His previous roles include head of global business development at Shire and business development and commercial positions at Glaxo Wellcome - now

  • Apitope strengthens its board with new director Apitope strengthens its board with new director

    William’s extensive drug development expertise is a valuable addition as we seek to advance development of our potential first-in-class antigen-specific treatments targeted at autoimmune diseases.

  • Lilly appoints Maura Dickler as VP of late phase oncology development Lilly appoints Maura Dickler as VP of late phase oncology development

    Maura Dickler is set to join Lilly Oncology as VP of late phase development on May 7. ... He said: "Dr Dickler is an internationally recognized oncology leader with drug development expertise spanning a wide range of therapeutic modalities.

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Bone Therapeutics strengthens board with new chairman Bone Therapeutics strengthens board with new chairman

    Thomas Lienard, chief executive officer of Bone Therapeutics, said: “Stéphenne has unparalleled experience in drug development and building innovative life science companies and is highly regarded within the sector.

More from appointments
Approximately 1 fully matching, plus 161 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics